Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2746 | 2159 | 37.1 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
14 | 4 | ORTHOPEDICS//DENTISTRY, ORAL SURGERY & MEDICINE//SPORT SCIENCES | 808941 |
32 | 3 | OSTEOPOROSIS//VITAMIN D//OSTEOPOROSIS INTERNATIONAL | 107093 |
1401 | 2 | BISPHOSPHONATES//ZOLEDRONIC ACID//BONE METASTASES | 8069 |
2746 | 1 | BISPHOSPHONATES//ZOLEDRONIC ACID//ALENDRONATE | 2159 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BISPHOSPHONATES | authKW | 1797933 | 36% | 16% | 784 |
2 | ZOLEDRONIC ACID | authKW | 955054 | 12% | 26% | 262 |
3 | ALENDRONATE | authKW | 281308 | 7% | 14% | 145 |
4 | ZOLEDRONATE | authKW | 220555 | 3% | 28% | 56 |
5 | FARNESYL PYROPHOSPHATE SYNTHASE | authKW | 142570 | 1% | 46% | 22 |
6 | YM529 | authKW | 100560 | 0% | 89% | 8 |
7 | CLODRONATE | authKW | 97236 | 2% | 15% | 47 |
8 | INCADRONATE | authKW | 95054 | 1% | 61% | 11 |
9 | BONE MUSCULOSKELETAL PROGRAMME | address | 86934 | 1% | 36% | 17 |
10 | PAMIDRONATE | authKW | 85457 | 3% | 11% | 54 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 2307 | 14% | 0% | 293 |
2 | Oncology | 1924 | 17% | 0% | 369 |
3 | Orthopedics | 1163 | 7% | 0% | 147 |
4 | Materials Science, Biomaterials | 1084 | 4% | 0% | 85 |
5 | Pharmacology & Pharmacy | 949 | 14% | 0% | 313 |
6 | Chemistry, Medicinal | 848 | 7% | 0% | 142 |
7 | Chemistry, Organic | 782 | 10% | 0% | 218 |
8 | Dentistry, Oral Surgery & Medicine | 581 | 5% | 0% | 100 |
9 | Rheumatology | 388 | 3% | 0% | 59 |
10 | Engineering, Biomedical | 372 | 4% | 0% | 83 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BONE MUSCULOSKELETAL PROGRAMME | 86934 | 1% | 36% | 17 |
2 | UMYMFOR CONICET FCEYN | 71583 | 0% | 56% | 9 |
3 | NUFFIELD ORTHOPAED SURGNUFFIELD ORTHOPAED C | 42425 | 0% | 100% | 3 |
4 | UNIT CLIN ONCOL | 42030 | 1% | 11% | 27 |
5 | MUSCULOSKELETAL SCINUFFIELD ORTHOPAED | 31817 | 0% | 75% | 3 |
6 | MOL REGULAT | 29484 | 1% | 19% | 11 |
7 | PHYSIOPATHOL ORPT OSSEUSE THER IE TUMEU | 29463 | 1% | 15% | 14 |
8 | ENDOCRINOL DIABET BONE METAB | 28283 | 0% | 100% | 2 |
9 | FUTURE PLAN NEW MAT ENGN | 28283 | 0% | 100% | 2 |
10 | SPINE SECT E | 28283 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BONE | 18713 | 4% | 1% | 94 |
2 | JOURNAL OF BONE AND MINERAL RESEARCH | 10640 | 3% | 1% | 71 |
3 | CALCIFIED TISSUE INTERNATIONAL | 7553 | 2% | 1% | 51 |
4 | JOURNAL OF BONE ONCOLOGY | 4617 | 0% | 5% | 6 |
5 | METABOLIC BONE DISEASE & RELATED RESEARCH | 3732 | 0% | 4% | 7 |
6 | PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS | 3270 | 2% | 0% | 49 |
7 | JOURNAL OF PERIODONTOLOGY | 2608 | 2% | 1% | 35 |
8 | ACTA ORTHOPAEDICA | 1343 | 1% | 1% | 12 |
9 | HETEROATOM CHEMISTRY | 1265 | 1% | 1% | 14 |
10 | JOURNAL OF ORTHOPAEDIC RESEARCH | 1252 | 1% | 0% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BISPHOSPHONATES | 1797933 | 36% | 16% | 784 | Search BISPHOSPHONATES | Search BISPHOSPHONATES |
2 | ZOLEDRONIC ACID | 955054 | 12% | 26% | 262 | Search ZOLEDRONIC+ACID | Search ZOLEDRONIC+ACID |
3 | ALENDRONATE | 281308 | 7% | 14% | 145 | Search ALENDRONATE | Search ALENDRONATE |
4 | ZOLEDRONATE | 220555 | 3% | 28% | 56 | Search ZOLEDRONATE | Search ZOLEDRONATE |
5 | FARNESYL PYROPHOSPHATE SYNTHASE | 142570 | 1% | 46% | 22 | Search FARNESYL+PYROPHOSPHATE+SYNTHASE | Search FARNESYL+PYROPHOSPHATE+SYNTHASE |
6 | YM529 | 100560 | 0% | 89% | 8 | Search YM529 | Search YM529 |
7 | CLODRONATE | 97236 | 2% | 15% | 47 | Search CLODRONATE | Search CLODRONATE |
8 | INCADRONATE | 95054 | 1% | 61% | 11 | Search INCADRONATE | Search INCADRONATE |
9 | PAMIDRONATE | 85457 | 3% | 11% | 54 | Search PAMIDRONATE | Search PAMIDRONATE |
10 | DRONIC ACIDS | 84849 | 0% | 100% | 6 | Search DRONIC+ACIDS | Search DRONIC+ACIDS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ROGERS, MJ , CROCKETT, JC , COXON, FP , MONKKONEN, J , (2011) BIOCHEMICAL AND MOLECULAR MECHANISMS OF ACTION OF BISPHOSPHONATES.BONE. VOL. 49. ISSUE 1. P. 34 -41 | 74 | 76% | 79 |
2 | RUSSELL, RGG , (2011) BISPHOSPHONATES: THE FIRST 40 YEARS.BONE. VOL. 49. ISSUE 1. P. 2 -19 | 77 | 47% | 281 |
3 | EBETINO, FH , HOGAN, AML , SUN, ST , TSOUMPRA, MK , DUAN, XC , TRIFFITT, JT , KWAASI, AA , DUNFORD, JE , BARNETT, BL , OPPERMANN, U , ET AL (2011) THE RELATIONSHIP BETWEEN THE CHEMISTRY AND BIOLOGICAL ACTIVITY OF THE BISPHOSPHONATES.BONE. VOL. 49. ISSUE 1. P. 20-33 | 61 | 77% | 108 |
4 | HUDSON, HR , WARDLE, NJ , BLIGH, SWA , GREINER, I , GRUN, A , KEGLEVICH, G , (2012) N-HETEROCYCLIC DRONIC ACIDS: APPLICATIONS AND SYNTHESIS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 12. ISSUE 4. P. 313-325 | 74 | 76% | 19 |
5 | ROELOFS, AJ , THOMPSON, K , GORDON, S , ROGERS, MJ , (2006) MOLECULAR MECHANISMS OF ACTION OF BISPHOSPHONATES: CURRENT STATUS.CLINICAL CANCER RESEARCH. VOL. 12. ISSUE 20. P. 6222S-6230S | 60 | 80% | 145 |
6 | ROGERS, MJ , (2004) FROM MOLDS AND MACROPHAGES TO MEVALONATE: A DECADE OF PROGRESS IN UNDERSTANDING THE MOLECULAR MODE OF ACTION OF BISPHOSPHONATES.CALCIFIED TISSUE INTERNATIONAL. VOL. 75. ISSUE 6. P. 451-461 | 74 | 76% | 83 |
7 | DUNFORD, JE , (2010) MOLECULAR TARGETS OF THE NITROGEN CONTAINING BISPHOSPHONATES: THE MOLECULAR PHARMACOLOGY OF PRENYL SYNTHASE INHIBITION.CURRENT PHARMACEUTICAL DESIGN. VOL. 16. ISSUE 27. P. 2961 -2969 | 64 | 75% | 26 |
8 | CHMIELEWSKA, E , KAFARSKI, P , (2016) SYNTHETIC PROCEDURES LEADING TOWARDS AMINOBISPHOSPHONATES.MOLECULES. VOL. 21. ISSUE 11. P. - | 78 | 58% | 0 |
9 | GREEN, JR , (2004) BISPHOSPHONATES: PRECLINICAL REVIEW.ONCOLOGIST. VOL. 9. ISSUE . P. 3-13 | 54 | 84% | 225 |
10 | FLEISCH, H , (1998) BISPHOSPHONATES: MECHANISMS OF ACTION.ENDOCRINE REVIEWS. VOL. 19. ISSUE 1. P. 80 -100 | 86 | 46% | 637 |
Classes with closest relation at Level 1 |